Applied Nanotech Receives $750K Grant to Develop Printable Inks for Solar Cells

Applied Nanotech Holdings, Inc. (OTC BB: APNT) announced that it has been selected by the U.S. Department of Energy to receive a contract of approximately $750,000 for the development of non-contact, printable metallic inks for silicon solar cells.

During this two year Phase II Small Business Innovation Research program, Applied Nanotech will focus on improving methods for the application of metallic electrodes to silicon photovoltaic (PV) substrates using its unique metallic nanoparticle-based inks. Electrical contacts are a critical part of PV technology and represent a difficult and costly area for solar cell production. This development program will exploit advances in nanotechnology to lower manufacturing costs and improve solar cell efficiency.

This program is particularly important since using very thin silicon wafers in an effort to reduce silicon usage has resulted in wafers that are susceptible to breakage when utilizing traditional contact printing methods such as screen printing.

"Our company is just beginning our foray into renewable energy. This funding will allow us to continue to build upon our expertise in development of nanoparticle-based technical inks for applications of global significance with strong commercial potential," stated Douglas Baker, CEO of Applied Nanotech Holdings, Inc.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.